Print

Acrux Limited Announces Positive Clinical Trial Results with Combination Contraceptive Sprays  
7/3/2007 1:00:19 PM

Acrux (ASX: ACR) -- The Australian drug delivery company, today announced positive results from its Phase 1 clinical studies using two unique contraceptive skin sprays, each containing a progestin and an estrogen.
//-->